Introduction:

Central Nervous System (CNS) Tuberculosis is a severe form of tuberculosis that affects the brain and spinal cord. It encompasses a range of clinical entities, including tuberculous meningitis, intracranial tuberculoma, and spinal tuberculous arachnoiditis. This article provides an in-depth look at the pathophysiology, clinical presentation, diagnostic workup, treatment strategies, and outcomes associated with CNS tuberculosis.

Pathophysiology:

• Mycobacterium tuberculosis infection in the CNS can occur through hematogenous spread from a primary site in the lungs or through direct extension from local structures.
• Formation of Tuberculomas: These are granulomas that can form in the brain or spinal cord, causing mass effect and neurological deficits.
• Meningitis: The most common and severe form, where the meninges are inflamed, leading to increased intracranial pressure and hydrocephalus.

Clinical Presentation:

• General Symptoms: Headache, fever, vomiting, and malaise.
• Neurological Deficits: Focal deficits, seizures, and altered mental status.
• Meningeal Signs: Neck stiffness, photophobia, and positive Kernig’s and Brudzinski’s signs.
• Advanced Disease: May lead to coma and life-threatening complications.

Diagnosis:

• Lumbar Puncture: Analysis of cerebrospinal fluid (CSF) for elevated protein, low glucose, lymphocytic pleocytosis, and the presence of acid-fast bacilli.
• CSF Culture and PCR: For definitive diagnosis, though cultures can take weeks to become positive.
• Imaging (MRI or CT): To identify tuberculomas, hydrocephalus, and infarcts due to arteritis.
• Chest X-Ray: To identify primary pulmonary TB.

Treatment:

• Antituberculous Therapy: Extended treatment with multiple drugs, including isoniazid, rifampicin, pyrazinamide, and ethambutol.
• Corticosteroids: To reduce inflammation, especially in cases of meningitis.
• Surgical Intervention: May be necessary for hydrocephalus (ventriculoperitoneal shunt) or to reduce the mass effect of large tuberculomas.
• Monitoring and Supportive Care: Regular neurological assessments and management of complications.

Prevention:

• Early Detection and Treatment: Of primary TB infections to prevent hematogenous spread.
• BCG Vaccination: Can offer some protection against severe forms of TB, including CNS involvement.
• Public Health Measures: Screening and treating latent TB, especially in high-risk populations.

Prognosis:

• Varies Widely: Depending on the severity at presentation, promptness of treatment, and development of complications.
• Long-Term Sequelae: Include neurological deficits and cognitive impairment, especially in children.

Conclusion:

CNS tuberculosis is a critical condition requiring early recognition and aggressive treatment to prevent serious outcomes. Multidisciplinary care involving infectious disease specialists, neurologists, and neurosurgeons is often necessary. Advances in diagnostic techniques and a better understanding of the disease have improved the management and prognosis of CNS TB, but it remains a significant challenge in endemic areas.

Hashtags: #CNSTuberculosis #TuberculousMeningitis #NeuroTB #InfectiousDiseases #Neurology #PublicHealth